Imidazo[1, 2-a] pyrazines for the treatment of irritable bowel syndrome
Abstract
Provided herein are methods for treating a subject afflicted with irritable bowel syndrome comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition that comprises a pharmaceutically acceptable carrier and a compound of the formula wherein: X is CHR 5 , NR 5 , O, S, S(O) n or a single bond, wherein n is equal to 0, 1 or 2; D is aryl or heteroaryl attached through an unsaturated carbon atom and wherein said aryl or heteroaryl is optionally substituted at any available position with from 1-5 of A 1 , A 2 , A 3 , A 4 and A 5 ; and R 2 is C 1-4 alkyl or C 3-8 cycloalkyl, each of which is optionally substituted with from 1-3 hydroxy, halogen or C 1-4 alkoxy, or wherein when X is a bond, R 2 is CN, CF 3 , or C 2 F 5 .
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating a subject afflicted with irritable bowel syndrome comprising administering to said subject a therapeutically effective amount of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of the formula I:
wherein:
X is CHR 5 , NR 5 , O, S, S(O) n or a single bond, wherein n is equal to 0, 1 or 2;
D is aryl or heteroaryl attached through an unsaturated carbon atom and wherein said aryl or heteroaryl is optionally substituted at any available position with from 1-5 of A 1 , A 2 , A 3 , A 4 and A 5 ; A 1 , A 2 , A 3 , A 4 and A 5 are each independently H, C 1-6 alkyl, C 3-6 cycloalkyl, halo, C 1-4 haloalkyl, cyano, nitro, —OR 12 , SH, —S(O) n R 13 , —COR 12 , —CO 2 R 12 , —OC(O)R 13 , —NR 11 COR 12 , —N(COR 12 ) 2 , —NR 11 CONR 12 R 14 , or wherein A 1 , A 2 , A 3 , A 4 and A 5 are each independently phenyl or phenyl substituted with from 1 to 4 of C 1-3 alkyl, C 1-3 alkoxy, halo, cyano, dimethylamino, CF 3 , C 2 F 5 , OCF 3 , SO 2 Me or acetyl;
R 1 is C 1-10 alkyl, C 2 -10 alkenyl, C 2-10 alkynyl, C 3-8 cycloalkyl, C 4-12 cycloalkylalkyl, NR 6 R 7 or —C(R 8 ) (R 9 )—O—R 10 ;
R 2 is C 1-4 alkyl or C 3-8 cycloalkyl, each of which is optionally substituted with from 1-3 hydroxy, halogen or C 1-4 alkoxy, or wherein when X is a bond, R 2 is CN, CF 3 , or C 2 F 5 ;
R 3 and R 4 are independently H, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-5 cycloalkyl, C 1-4 alkoxy, C 1-4 haloalkyl, C 1-4 haloalkoxy, halogen, CN, or NR 6 R 7 ;
R 5 is H, C 1-4 alkyl or C 3-8 cycloalkyl;
R 6 and R 7 are each independently H, C 1-4 alkyl, C 1-4 haloalkyl, C 2-8 alkoxyalkyl, C 3-6 cycloalkyl, C 4-12 cycloalkylalkyl, aryl, aryl(C 1-4 alkyl)-, heteroaryl or heteroaryl(C 1-4 alkyl)-;
R 8 and R 9 are each independently H or C 1-4 alkyl, or R 8 and R 9 are taken together as ═CH 2 ;
R 10 is H or C1-4 alkyl;
R 11 is H, C 1-4 alkyl, C 3-7 cycloalkyl, C 4-12 cycloalkylalkyl, phenyl or benzyl, each phenyl or benzyl optionally substituted on the aryl moiety with 1-3 groups of C 1-4 alkyl, halogen, C 1-4 haloalkyl, nitro, C 1-4 alkoxy, C 1-4 haloalkoxy, or dimethylamino; and,
R 12 , R 13 and R 14 are each independently H, C 1-6 alkyl, C 3-10 cycloalkyl, C 4-16 cycloalkylalkyl or C 1-4 haloalkyl.
2 . The method of claim 1 , wherein X is a single bond.
3 . The method of claim 1 , wherein D is phenyl.
4 . The method of claim 3 , wherein the phenyl is
and wherein each of A 1 , A 2 and A 3 is independently H, C 1-6 alkyl, C 1-6 alkoxy, halogen, C 1-4 haloalkyl or OR 12 .
5 . The method of claim 4 , wherein A 1 is H, CH 3 or Cl.
6 . The method of claim 4 , wherein A 2 is Cl, —OCH 3 or —OCHF 2 .
7 . The method of claim 4 , wherein A 3 is H or CH 3 .
8 . The method of claim 4 , wherein: A 1 is H, CH 3 or Cl; A 2 is Cl, —OCH 3 or —OCHF 2 and A 3 is H or CH 3 .
9 . The method of claim 1 , wherein R 1 is —C(R 8 )(R 9 )—O—R 10 .
10 . The method of claim 9 , wherein each of R 8 , R 9 and R 10 are independently H or C 1-4 alkyl.
11 . The method of claim 10 , wherein R 8 is H.
12 . The method of claim 10 , wherein R 9 is C 2 H 5 or C 3 H 7 .
13 . The method of claim 12 , wherein R 10 is H.
14 . The method of claim 10 , wherein R 8 is H, R 9 is C 2 H 5 or C 3 H 7 and R 10 is H.
15 . The method of claim 1 , wherein R 2 is unsubstituted C1-4 alkyl.
16 . The method of claim 15 , wherein R 1 is C 2 H 5 .
17 . The method of claim 1 , wherein each of R 3 and R 4 are H 18. The method of claim 1 , wherein R 1 is —C(R 8 )(R 9 )—O—R 10 , R is unsubstituted C 1-4 alkyl, each of R 3 and R 4 is H, X is a single bond and D is phenyl of the formula
wherein R 8 is H, R 9 is C 2 H 5 or C 3 H 7 , R 10 is H, each of Al, is H, A 2 is Cl, —OCH 3 or —OCHF 2 and A 3 is H.Join the waitlist — get patent alerts
Track US2003220342A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.